PFE Sep 2024 15.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:05PM EDT. Market open.
| Previous close | 13.04 |
| Open | 13.04 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 15.00 |
| Expiry date | 2024-09-20 |
| Day's range | 13.04 - 13.04 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
GuruFocus.comDecoding Pfizer Inc (PFE): A Strategic SWOT Insight
Insightful Analysis of Pfizer Inc's Financial Health and Strategic Position
BloombergModerna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion biotech giant and a public health hero. Its second vaccine, meant to prevent a common respiratory virus, is calling into question the premise on which the company has staked its entire business. Most Read from BloombergMicrosoft’s Xbox Is Planning More Cuts After Studio ClosingsAmericans Are Racking Up ‘Phantom Debt’ That Wall Street Can’t Track‘Seriously Underwater’ Home Mortgages Tick Up Across th
Investor's Business DailyPfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Pfizer stock ran up to its 50-day line after the company reported better-than-expected sales and profit. Is PFE stock a buy?
© 2024 Yahoo. All rights reserved.